What is measured by B-type natriuretic peptide (BNP)?

• A. Acute renal failure
• B. Acute congestive heart failure (CHF)
• C. Acute myocardial infarction
• D. Hypoxia

Answer: (B)

B-type natriuretic peptide (BNP) is a hormone produced by the heart in response to ventricular volume expansion and pressure overload, with its levels being significantly elevated in patients with heart failure, particularly congestive heart failure (CHF). Measuring BNP levels is clinically valuable because it helps differentiate between cardiac and non-cardiac causes of dyspnea in patients presenting to the emergency department.

When the heart is under stress due to conditions such as CHF, the ventricles release more BNP as part of a compensatory mechanism aimed at reducing cardiac stress and promoting natriuresis, diuresis, and vasodilation. Elevated BNP levels correlate with the severity of heart failure and can guide diagnosis, treatment decisions, and prognosis.

In contrast, the other conditions listed do not have a direct relationship with BNP levels. For instance, acute renal failure can affect fluid status but is not characterized by specific hormonal responses akin to BNP. Acute myocardial infarction might influence BNP levels due to cardiac stress, but it is not a direct measure of the myocardial infarction itself. Hypoxia might occur in various contexts, but it does not correlate directly with BNP production. Thus, the measurement of BNP is most closely linked to assessing and diagnosing acute congestive heart